Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 40,178 shares at $25.11 ($1.0M) on 2023-04-14, disclosed to the SEC on 2023-04-18.
Open-market sale of $1.0M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.11 | 9,565 | $240K | 23.8% |
| 2 | $25.11 | 9,565 | $240K | 23.8% |
| 3 | $25.06 | 10,524 | $264K | 26.2% |
| 4 | $25.06 | 10,524 | $264K | 26.2% |
| Total | $25.08 avg | 40,178 | $1.0M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-02-17 | $1.0M | — | Filing → |